William J Phd Link insider trades: Tarsus Pharmaceuticals (TARS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
and 12 more companies
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TARS | ↓ Sell | 12,500 | $78.38 | $980K | Direct | Sep 17, 2026 (2d) |
| Jun 15, 2026 | TARS | ↓ Sell | 12,500 | $62.12 | $776K | Direct | Jun 17, 2026 (2d) |
| Mar 16, 2026 | TARS | ↓ Sell | 12,500 | $68.79 | $860K | Direct | Mar 18, 2026 (2d) |
| Dec 15, 2025 | TARS | ↓ Sell | 12,500 | $81.43 | $1.0M | Direct | Dec 17, 2025 (2d) |
| Dec 15, 2025 | TARS | ↓ Sell | 10,446 | $81.07 | $847K | By Link Family Enterprise, LP | Dec 17, 2025 (2d) |
| Sep 8, 2025 | TARS | ↓ Sell | 27,116 | $57.00 | $1.5M | Direct | Sep 10, 2025 (2d) |
| Aug 12, 2024 | TARS | ↓ Sell | 35,000 | $26.08 | $913K | By Flying L Partners XI, LLC | Aug 14, 2024 (2d) |
| Feb 1, 2024 | RXST | ↓ Sell | 28,250 | $49.67 | $1.4M | Indirect | Feb 2, 2024 (1d) |
| Oct 18, 2021 | OYST | ↓ Sell | 550,000 | $14.84 | $8.2M | Indirect | Oct 20, 2021 (2d) |
| Aug 3, 2021 | RXST | ↑ Buy | 31,250 | $16.00 | $500K | Direct | Aug 5, 2021 (2d) |
| Dec 1, 2020 | GKOS | ↓ Sell | 50,000 | $67.97 | $3.4M | Direct | Dec 3, 2020 (2d) |
| Nov 4, 2019 | OYST | ↑ Buy | 27,500 | $16.00 | $440K | Indirect | Nov 4, 2019 (0d) |
| Aug 21, 2019 | EW | ↓ Sell | 8,564 | $221.83 | $1.9M | Direct | Aug 21, 2019 (0d) |
| Aug 21, 2019 | EW | ↓ Sell | 1,650 | $222.02 | $366K | Link Family Enterprise, LP | Aug 21, 2019 (0d) |
| Nov 19, 2018 | EW | ↓ Sell | 10,950 | $149.88 | $1.6M | Link Family Trust | Nov 20, 2018 (1d) |
| Nov 19, 2018 | EW | ↓ Sell | 2,628 | $150.06 | $394K | Link Family Enterprise, LP | Nov 20, 2018 (1d) |
| Nov 15, 2018 | GKOS | ↓ Sell | 41,500 | $57.62 | $2.4M | Indirect | Nov 15, 2018 (0d) |
| Feb 9, 2018 | EW | ↓ Sell | 12,000 | $122.24 | $1.5M | * | Feb 13, 2018 (4d) |
| Nov 29, 2016 | EW | ↓ Sell | 15,000 | $84.01 | $1.3M | * | Dec 1, 2016 (2d) |
| Nov 17, 2016 | GKOS | ↓ Sell | 30,000 | $33.78 | $1.0M | Indirect | Nov 18, 2016 (1d) |
| Jun 8, 2016 | FLXN | ↑ Buy | 714,285 | $14.00 | $10.0M | Indirect | Jun 10, 2016 (2d) |
| May 31, 2016 | GKOS | ↓ Sell | 34,058 | $23.98 | $817K | Indirect | Jun 2, 2016 (2d) |
| May 31, 2016 | GKOS | ↓ Sell | 34,058 | $23.98 | $817K | Indirect | Jun 2, 2016 (2d) |
| May 23, 2016 | PZRX | ↑ Buy | 596,477 | $5.00 | $3.0M | By Versant Venture Capital III, L.P. | May 24, 2016 (1d) |
| May 23, 2016 | PZRX | ↑ Buy | 3,523 | $5.00 | $18K | By Versant Side Fund III, L.P. | May 24, 2016 (1d) |
| May 23, 2016 | PZRX | ↓ Sell | 256,529 | $0.01 | $3K | By Versant Venture Capital III, L.P. | May 24, 2016 (1d) |
| May 23, 2016 | PZRX | ↓ Sell | 1,515 | $0.01 | $15 | By Versant Side Fund III, L.P. | May 24, 2016 (1d) |
| Nov 17, 2014 | INGN | ↓ Sell | 5,343 | $24.89 | $133K | Indirect | Nov 19, 2014 (2d) |
| Nov 14, 2014 | INGN | ↓ Sell | 9,433 | $25.13 | $237K | Indirect | Nov 14, 2014 (0d) |
| Nov 10, 2014 | INGN | ↓ Sell | 2,992 | $24.42 | $73K | By Colella Family Partners and Colella F | Nov 12, 2014 (2d) |
| Nov 7, 2014 | INGN | ↓ Sell | 7,388 | $24.30 | $180K | Indirect | Nov 7, 2014 (0d) |
| Oct 24, 2014 | INGN | ↓ Sell | 4,647 | $20.76 | $96K | by Robertson Family Trust | Oct 28, 2014 (4d) |
| Oct 9, 2014 | INGN | ↓ Sell | 1,756 | $20.83 | $37K | By Lubash Moses LLC | Oct 14, 2014 (5d) |
| Oct 9, 2014 | INGN | ↓ Sell | 144 | $20.83 | $3K | By Evan Michael Moses Trust | Oct 14, 2014 (5d) |
| Oct 8, 2014 | INGN | ↓ Sell | 6,382 | $21.03 | $134K | By Lubash Moses LLC | Oct 9, 2014 (1d) |
| Oct 8, 2014 | INGN | ↓ Sell | 525 | $21.03 | $11K | By Evan Michael Moses Trust | Oct 9, 2014 (1d) |
| Sep 9, 2014 | INGN | ↓ Sell | 7,388 | $23.25 | $172K | see footnore | Sep 12, 2014 (3d) |
| Sep 18, 2009 | HLCS | ↑ Buy | 242,931 | $2.57 | $625K | Versant Venture Capital II, L.P. | Sep 21, 2009 (3d) |
| May 30, 2007 | HLCS | ↑ Buy | 111,111 | $9.00 | $1000K | Versant Venture Capital II, L.P. | Jun 1, 2007 (2d) |
| Jan 12, 2007 | ILSE | ↓ Sell | 250,000 | $24.52 | $6.1M | By Ltd. Partnership | Jan 17, 2007 (5d) |
| May 9, 2006 | ILSE | ↓ Sell | 50,000 | $20.33 | $1.0M | By Ltd. Partnership | May 11, 2006 (2d) |
| Jul 25, 2005 | EYE | ↓ Sell | 26,500 | $40.23 | $1.1M | Direct | Jul 27, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TARS insiders
Open-market trades in the last 12 months
About William J Phd Link's insider trades
William J Phd Link is a director at Tarsus Pharmaceuticals (TARS). Since Jul 25, 2005, William has reported 7 open-market purchases worth $15.6M and 35 sales worth $41.3M on SEC Form 4. In the last 12 months: 5 sales ($4.5M).
Their filings also include grants and awards (59 filings), other transactions (37 filings), option exercises (10 filings), conversions (10 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TARS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.